Arvinas, Inc. (ARVN)
11.84
-1.26
(-9.59%)
USD |
NASDAQ |
Feb 12, 16:00
11.70
-0.14
(-1.14%)
After-Hours: 06:12
Arvinas Cash from Investing (Quarterly) : 63.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Genprex, Inc. | 0.00 |
| Olema Pharmaceuticals, Inc. | 17.27M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -59.10M |
| Cash from Financing (Quarterly) | -17.80M |
| Free Cash Flow | -329.50M |
| Free Cash Flow Per Share (Quarterly) | -0.8087 |
| Free Cash Flow to Equity (Quarterly) | -58.60M |
| Free Cash Flow to Firm (Quarterly) | -59.20M |
| Free Cash Flow Yield | -38.27% |